by Katy Keating | Apr 11, 2025 | Blog
In the summer of 2024, EmVenio launched brick-and-mortar clinical trial research centers on select Prime hospital campuses. Like our mobile community research sites, these locations were strategically chosen using social determinants of health of the surrounding...
by EmVenio | Feb 17, 2025 | Blog
This February, EmVenio team members, along with our parent company PCM Trials, attended the 16th annual SCOPE Summit in Orlando, Florida. We were excited to see familiar and new faces and share more about our innovations and success in clinical research. At the...
by EmVenio | Oct 21, 2024 | Blog
At EmVenio, we believe community intervention is the first step to creating inclusivity and trust in clinical research. This month, we had the privilege of meeting community members of the Greater Atlanta area at “Reflections Atlanta: Illuminating Diversity in...
by Katy Keating | Oct 17, 2024 | Blog
EmVenio has been an active member in the Society of Clinical Research Sites since our founding in 2022, and many of our team members have been involved in the SCRS community over the course of their careers. We also recently joined SCRS’s Global Impact Partner...
by Katy Keating | Oct 16, 2024 | Blog
EmVenio leadership and staff gathered in late September for a ribbon-cutting and open house at one of our first clinical trial research centers within the Prime Healthcare hospital system. This location is inside the Southern Regional Medical Center in Riverdale,...
by EmVenio | Aug 14, 2024 | Blog
The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s...
